Bausch + Lomb (NYSE:BLCO – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens ...
The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...
Wells Fargo analyst Larry Biegelsen has maintained their bullish stance on BLCO stock, giving a Buy rating on October 22. Larry ...
One Bloomberg estimate projected the sale to value Bausch + Lomb at over $13 billion, making the deal potentially one of the ...
Designed to help maximize efficiencies for eye care practices while enhancing the patient experience, Opal provides a streamlined ordering process for Bausch + Lomb contact lenses, with select ...
Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twelve ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...
Cathleen McCabe, MD has joined Bausch + Lomb as strategic medical advisor. Palvella Therapeutics named Matthew E. Korenberg as CFO. Disc Medicine appointed Rahul Kaushik as CTO. Inspire, an online ...
(Bloomberg) -- Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout of Bausch Lomb, according to people with knowledge of ...
Designed to help maximize efficiencies for eye care practices while enhancing the patient experience, Opal provides a streamlined ordering process for Bausch + Lomb contact lenses, with select Bausch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results